The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
140 - If we place an ad in an HCP-focused journal, and provide a link to an HCP-focused website (either typed in or scanned using a 2-D scan code), can we assume that the audience has been sufficiently vetted as HCPs and provide branded drug information to them? This would be in lieu of asking for licence numbers or other means of identification.
Electronic Media
1
Posts
1
Posters
314
Views
1
Watching
-
For prescription products and for drugs indicated to treat/cure Schedule A diseases, a gate of some sort is required to pose a true barrier restricting consumers from having access to the site. The relevant legislative authority is Section C.01.044 of the FDR and Section 3 of the FDA. The assumption in your question is only valid if the website is not searchable. In other words, the website could only be accessible to those who use the scan code or type that specific URL into the search field. Please call if you have any questions.
